Xenon Pharmaceuticals Inc. 4
4 · Xenon Pharmaceuticals Inc. · Filed Dec 21, 2015
Insider Transaction Report
Form 4
GOLDBERG Y. PAUL
VP of Clinical Development
Transactions
- Award
Stock Option (Right to Buy)
2015-12-18+15,000→ 15,000 totalExercise: $7.69Exp: 2025-12-17→ Common Shares (15,000 underlying)
Footnotes (1)
- [F1]Vesting 25% on December 18, 2016, and 75% vesting thereafter over the course of the next 3 years, in equal amounts, on the last day of each month.